 | • レポートコード：QYR2104Z4496 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ペプチド＆ヘパリンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、経口経路、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペプチド＆ヘパリンの市場動向 ・企業の競争状況、市場シェア ・ペプチド＆ヘパリンの種類別市場規模（静脈内、経口経路、その他） ・ペプチド＆ヘパリンの用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・ペプチド＆ヘパリンの北米市場規模2016-2027（アメリカ、カナダ） ・ペプチド＆ヘパリンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチド＆ヘパリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチド＆ヘパリンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチド＆ヘパリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Novo Nordisk、Sanofi、Pfizer、Abbott Laboratories、Takeda、Teva、Leo Pharma、Aspen、Bachem、Hemmo Pharma、Sun Pharmaceutical、Wockhardt、AmbioPharm） ・結論 |
Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.
Market Analysis and Insights: Global Peptide and Heparin Market
The global Peptide and Heparin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide and Heparin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide and Heparin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide and Heparin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide and Heparin market.
Global Peptide and Heparin Scope and Market Size
Peptide and Heparin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide and Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intravenous
Oral Route
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
Novo Nordisk
Sanofi
Pfizer
Abbott Laboratories
Takeda
Teva
Leo Pharma
Aspen
Pfizer
Abbott Laboratories
Sun Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide and Heparin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Oral Route
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide and Heparin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide and Heparin Market Perspective (2016-2027)
2.2 Peptide and Heparin Growth Trends by Regions
2.2.1 Peptide and Heparin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide and Heparin Historic Market Share by Regions (2016-2021)
2.2.3 Peptide and Heparin Forecasted Market Size by Regions (2022-2027)
2.3 Peptide and Heparin Industry Dynamic
2.3.1 Peptide and Heparin Market Trends
2.3.2 Peptide and Heparin Market Drivers
2.3.3 Peptide and Heparin Market Challenges
2.3.4 Peptide and Heparin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide and Heparin Players by Revenue
3.1.1 Global Top Peptide and Heparin Players by Revenue (2016-2021)
3.1.2 Global Peptide and Heparin Revenue Market Share by Players (2016-2021)
3.2 Global Peptide and Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide and Heparin Revenue
3.4 Global Peptide and Heparin Market Concentration Ratio
3.4.1 Global Peptide and Heparin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide and Heparin Revenue in 2020
3.5 Peptide and Heparin Key Players Head office and Area Served
3.6 Key Players Peptide and Heparin Product Solution and Service
3.7 Date of Enter into Peptide and Heparin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide and Heparin Breakdown Data by Type
4.1 Global Peptide and Heparin Historic Market Size by Type (2016-2021)
4.2 Global Peptide and Heparin Forecasted Market Size by Type (2022-2027)
5 Peptide and Heparin Breakdown Data by Application
5.1 Global Peptide and Heparin Historic Market Size by Application (2016-2021)
5.2 Global Peptide and Heparin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peptide and Heparin Market Size (2016-2027)
6.2 North America Peptide and Heparin Market Size by Type
6.2.1 North America Peptide and Heparin Market Size by Type (2016-2021)
6.2.2 North America Peptide and Heparin Market Size by Type (2022-2027)
6.2.3 North America Peptide and Heparin Market Size by Type (2016-2027)
6.3 North America Peptide and Heparin Market Size by Application
6.3.1 North America Peptide and Heparin Market Size by Application (2016-2021)
6.3.2 North America Peptide and Heparin Market Size by Application (2022-2027)
6.3.3 North America Peptide and Heparin Market Size by Application (2016-2027)
6.4 North America Peptide and Heparin Market Size by Country
6.4.1 North America Peptide and Heparin Market Size by Country (2016-2021)
6.4.2 North America Peptide and Heparin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Peptide and Heparin Market Size (2016-2027)
7.2 Europe Peptide and Heparin Market Size by Type
7.2.1 Europe Peptide and Heparin Market Size by Type (2016-2021)
7.2.2 Europe Peptide and Heparin Market Size by Type (2022-2027)
7.2.3 Europe Peptide and Heparin Market Size by Type (2016-2027)
7.3 Europe Peptide and Heparin Market Size by Application
7.3.1 Europe Peptide and Heparin Market Size by Application (2016-2021)
7.3.2 Europe Peptide and Heparin Market Size by Application (2022-2027)
7.3.3 Europe Peptide and Heparin Market Size by Application (2016-2027)
7.4 Europe Peptide and Heparin Market Size by Country
7.4.1 Europe Peptide and Heparin Market Size by Country (2016-2021)
7.4.2 Europe Peptide and Heparin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peptide and Heparin Market Size (2016-2027)
8.2 Asia-Pacific Peptide and Heparin Market Size by Type
8.2.1 Asia-Pacific Peptide and Heparin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide and Heparin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide and Heparin Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide and Heparin Market Size by Application
8.3.1 Asia-Pacific Peptide and Heparin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide and Heparin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide and Heparin Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide and Heparin Market Size by Region
8.4.1 Asia-Pacific Peptide and Heparin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide and Heparin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide and Heparin Market Size (2016-2027)
9.2 Latin America Peptide and Heparin Market Size by Type
9.2.1 Latin America Peptide and Heparin Market Size by Type (2016-2021)
9.2.2 Latin America Peptide and Heparin Market Size by Type (2022-2027)
9.2.3 Latin America Peptide and Heparin Market Size by Type (2016-2027)
9.3 Latin America Peptide and Heparin Market Size by Application
9.3.1 Latin America Peptide and Heparin Market Size by Application (2016-2021)
9.3.2 Latin America Peptide and Heparin Market Size by Application (2022-2027)
9.3.3 Latin America Peptide and Heparin Market Size by Application (2016-2027)
9.4 Latin America Peptide and Heparin Market Size by Country
9.4.1 Latin America Peptide and Heparin Market Size by Country (2016-2021)
9.4.2 Latin America Peptide and Heparin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide and Heparin Market Size (2016-2027)
10.2 Middle East & Africa Peptide and Heparin Market Size by Type
10.2.1 Middle East & Africa Peptide and Heparin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide and Heparin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide and Heparin Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide and Heparin Market Size by Application
10.3.1 Middle East & Africa Peptide and Heparin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide and Heparin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide and Heparin Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide and Heparin Market Size by Country
10.4.1 Middle East & Africa Peptide and Heparin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide and Heparin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Peptide and Heparin Introduction
11.1.4 Eli Lilly Revenue in Peptide and Heparin Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Peptide and Heparin Introduction
11.2.4 Novo Nordisk Revenue in Peptide and Heparin Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Peptide and Heparin Introduction
11.3.4 Sanofi Revenue in Peptide and Heparin Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Peptide and Heparin Introduction
11.4.4 Pfizer Revenue in Peptide and Heparin Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Peptide and Heparin Introduction
11.5.4 Abbott Laboratories Revenue in Peptide and Heparin Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Peptide and Heparin Introduction
11.6.4 Takeda Revenue in Peptide and Heparin Business (2016-2021)
11.6.5 Takeda Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Peptide and Heparin Introduction
11.7.4 Teva Revenue in Peptide and Heparin Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Leo Pharma
11.8.1 Leo Pharma Company Details
11.8.2 Leo Pharma Business Overview
11.8.3 Leo Pharma Peptide and Heparin Introduction
11.8.4 Leo Pharma Revenue in Peptide and Heparin Business (2016-2021)
11.8.5 Leo Pharma Recent Development
11.9 Aspen
11.9.1 Aspen Company Details
11.9.2 Aspen Business Overview
11.9.3 Aspen Peptide and Heparin Introduction
11.9.4 Aspen Revenue in Peptide and Heparin Business (2016-2021)
11.9.5 Aspen Recent Development
11.10 Bachem
11.10.1 Bachem Company Details
11.10.2 Bachem Business Overview
11.10.3 Bachem Peptide and Heparin Introduction
11.10.4 Bachem Revenue in Peptide and Heparin Business (2016-2021)
11.10.5 Bachem Recent Development
11.11 Hemmo Pharma
11.11.1 Hemmo Pharma Company Details
11.11.2 Hemmo Pharma Business Overview
11.11.3 Hemmo Pharma Peptide and Heparin Introduction
11.11.4 Hemmo Pharma Revenue in Peptide and Heparin Business (2016-2021)
11.11.5 Hemmo Pharma Recent Development
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Details
11.12.2 Sun Pharmaceutical Business Overview
11.12.3 Sun Pharmaceutical Peptide and Heparin Introduction
11.12.4 Sun Pharmaceutical Revenue in Peptide and Heparin Business (2016-2021)
11.12.5 Sun Pharmaceutical Recent Development
11.13 Wockhardt
11.13.1 Wockhardt Company Details
11.13.2 Wockhardt Business Overview
11.13.3 Wockhardt Peptide and Heparin Introduction
11.13.4 Wockhardt Revenue in Peptide and Heparin Business (2016-2021)
11.13.5 Wockhardt Recent Development
11.14 AmbioPharm
11.14.1 AmbioPharm Company Details
11.14.2 AmbioPharm Business Overview
11.14.3 AmbioPharm Peptide and Heparin Introduction
11.14.4 AmbioPharm Revenue in Peptide and Heparin Business (2016-2021)
11.14.5 AmbioPharm Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Peptide and Heparin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous
Table 3. Key Players of Oral Route
Table 4. Key Players of Others
Table 5. Global Peptide and Heparin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peptide and Heparin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide and Heparin Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peptide and Heparin Market Share by Regions (2016-2021)
Table 9. Global Peptide and Heparin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peptide and Heparin Market Share by Regions (2022-2027)
Table 11. Peptide and Heparin Market Trends
Table 12. Peptide and Heparin Market Drivers
Table 13. Peptide and Heparin Market Challenges
Table 14. Peptide and Heparin Market Restraints
Table 15. Global Peptide and Heparin Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peptide and Heparin Market Share by Players (2016-2021)
Table 17. Global Top Peptide and Heparin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide and Heparin as of 2020)
Table 18. Ranking of Global Top Peptide and Heparin Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peptide and Heparin Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide and Heparin Product Solution and Service
Table 22. Date of Enter into Peptide and Heparin Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peptide and Heparin Revenue Market Share by Type (2016-2021)
Table 26. Global Peptide and Heparin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peptide and Heparin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peptide and Heparin Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peptide and Heparin Revenue Market Share by Application (2016-2021)
Table 30. Global Peptide and Heparin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peptide and Heparin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peptide and Heparin Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peptide and Heparin Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peptide and Heparin Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peptide and Heparin Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peptide and Heparin Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peptide and Heparin Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peptide and Heparin Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peptide and Heparin Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peptide and Heparin Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peptide and Heparin Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peptide and Heparin Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peptide and Heparin Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peptide and Heparin Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peptide and Heparin Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peptide and Heparin Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peptide and Heparin Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peptide and Heparin Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peptide and Heparin Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peptide and Heparin Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peptide and Heparin Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peptide and Heparin Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peptide and Heparin Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peptide and Heparin Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peptide and Heparin Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peptide and Heparin Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peptide and Heparin Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly Company Details
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Peptide and Heparin Product
Table 65. Eli Lilly Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Novo Nordisk Company Details
Table 68. Novo Nordisk Business Overview
Table 69. Novo Nordisk Peptide and Heparin Product
Table 70. Novo Nordisk Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 71. Novo Nordisk Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Peptide and Heparin Product
Table 75. Sanofi Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Peptide and Heparin Product
Table 80. Pfizer Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Peptide and Heparin Product
Table 85. Abbott Laboratories Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 86. Abbott Laboratories Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Peptide and Heparin Product
Table 90. Takeda Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Peptide and Heparin Product
Table 95. Teva Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 96. Teva Recent Development
Table 97. Leo Pharma Company Details
Table 98. Leo Pharma Business Overview
Table 99. Leo Pharma Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 100. Leo Pharma Recent Development
Table 101. Aspen Company Details
Table 102. Aspen Business Overview
Table 103. Aspen Peptide and Heparin Product
Table 104. Aspen Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 105. Aspen Recent Development
Table 106. Bachem Company Details
Table 107. Bachem Business Overview
Table 108. Bachem Peptide and Heparin Product
Table 109. Bachem Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 110. Bachem Recent Development
Table 111. Hemmo Pharma Company Details
Table 112. Hemmo Pharma Business Overview
Table 113. Hemmo Pharma Peptide and Heparin Product
Table 114. Hemmo Pharma Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 115. Hemmo Pharma Recent Development
Table 116. Sun Pharmaceutical Company Details
Table 117. Sun Pharmaceutical Business Overview
Table 118. Sun Pharmaceutical Peptide and Heparin Product
Table 119. Sun Pharmaceutical Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 120. Sun Pharmaceutical Recent Development
Table 121. Wockhardt Company Details
Table 122. Wockhardt Business Overview
Table 123. Wockhardt Peptide and Heparin Product
Table 124. Wockhardt Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 125. Wockhardt Recent Development
Table 126. AmbioPharm Company Details
Table 127. AmbioPharm Business Overview
Table 128. AmbioPharm Peptide and Heparin Product
Table 129. AmbioPharm Revenue in Peptide and Heparin Business (2016-2021) & (US$ Million)
Table 130. AmbioPharm Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide and Heparin Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Features
Figure 3. Oral Route Features
Figure 4. Others Features
Figure 5. Global Peptide and Heparin Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Peptide and Heparin Report Years Considered
Figure 10. Global Peptide and Heparin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Peptide and Heparin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Peptide and Heparin Market Share by Regions: 2020 VS 2027
Figure 13. Global Peptide and Heparin Market Share by Regions (2022-2027)
Figure 14. Global Peptide and Heparin Market Share by Players in 2020
Figure 15. Global Top Peptide and Heparin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide and Heparin as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Peptide and Heparin Revenue in 2020
Figure 17. Global Peptide and Heparin Revenue Market Share by Type (2016-2021)
Figure 18. Global Peptide and Heparin Revenue Market Share by Type (2022-2027)
Figure 19. North America Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Peptide and Heparin Market Share by Type (2016-2027)
Figure 21. North America Peptide and Heparin Market Share by Application (2016-2027)
Figure 22. North America Peptide and Heparin Market Share by Country (2016-2027)
Figure 23. United States Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide and Heparin Market Share by Type (2016-2027)
Figure 27. Europe Peptide and Heparin Market Share by Application (2016-2027)
Figure 28. Europe Peptide and Heparin Market Share by Country (2016-2027)
Figure 29. Germany Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide and Heparin Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Peptide and Heparin Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Peptide and Heparin Market Share by Region (2016-2027)
Figure 39. China Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide and Heparin Market Share by Type (2016-2027)
Figure 47. Latin America Peptide and Heparin Market Share by Application (2016-2027)
Figure 48. Latin America Peptide and Heparin Market Share by Country (2016-2027)
Figure 49. Mexico Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide and Heparin Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Peptide and Heparin Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Peptide and Heparin Market Share by Country (2016-2027)
Figure 55. Turkey Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Peptide and Heparin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 59. Novo Nordisk Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 65. Leo Pharma Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 66. Aspen Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 67. Bachem Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 68. Hemmo Pharma Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 69. Sun Pharmaceutical Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 70. Wockhardt Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 71. AmbioPharm Revenue Growth Rate in Peptide and Heparin Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のペプチドベース癌治療薬市場規模・現状・予測（2021年-2027年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…
- 世界のペプチドベース心血管治療薬市場規模・現状・予測（2021年-2027年） Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…